Literature DB >> 26530359

The Role of Metabolomics in the Study of Cancer Biomarkers and in the Development of Diagnostic Tools.

Jean-Pierre Trezzi1, Nikos Vlassis2, Karsten Hiller3.   

Abstract

This chapter introduces the emerging field of metabolomics and its application in the context of cancer biomarker research. Taking advantage of modern high-throughput technologies, and enhanced computational power, metabolomics has a high potential for cancer biomarker identification and the development of diagnostic tools. This chapter describes current metabolomics technologies used in cancer research, starting with metabolomics sample preparation, elaborating on current analytical methodologies for metabolomics measurement and introducing existing software for data analysis. The last part of this chapter deals with the statistical analysis of very large metabolomics datasets and their relevance for cancer biomarker identification.

Entities:  

Keywords:  Analysis of body fluids; Biomarker determination; Cerebrospinal fluid (CSF); Data normalization; Diagnostic tool; Feces analysis; Gas chromatography; High-performance liquid chromatography (HPLC); Liquid chromatography; Mass spectrometry; Metabolite extraction; Metabolites; Metabolomics; Metabolomics data analysis tools; Metabolomics datasets; Metabolomics technologies; Metabolomics workflow; NMR spectroscopy; Plasma analysis; Primary metabolites; Saliva analysis; Secondary metabolites; Serum analysis; Statistical analysis; Urine analysis

Mesh:

Substances:

Year:  2015        PMID: 26530359     DOI: 10.1007/978-94-017-7215-0_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  13 in total

Review 1.  Metabolomic signature of brain cancer.

Authors:  Renu Pandey; Laura Caflisch; Alessia Lodi; Andrew J Brenner; Stefano Tiziani
Journal:  Mol Carcinog       Date:  2017-07-17       Impact factor: 4.784

Review 2.  Recent Advances in NMR-Based Metabolomics.

Authors:  G A Nagana Gowda; Daniel Raftery
Journal:  Anal Chem       Date:  2016-12-02       Impact factor: 6.986

Review 3.  Application of metabolomics in sarcoma: From biomarkers to therapeutic targets.

Authors:  Li Min; Edwin Choy; Chongqi Tu; Francis Hornicek; Zhenfeng Duan
Journal:  Crit Rev Oncol Hematol       Date:  2017-05-13       Impact factor: 6.312

4.  A non-invasive approach to explore the discriminatory potential of the urinary volatilome of invasive ductal carcinoma of the breast.

Authors:  Khushman Taunk; Ravindra Taware; Tushar H More; Priscilla Porto-Figueira; Jorge A M Pereira; Rajkishore Mohapatra; Dharmesh Soneji; José S Câmara; H A Nagarajaram; Srikanth Rapole
Journal:  RSC Adv       Date:  2018-07-12       Impact factor: 4.036

5.  Quantification of Salivary Charged Metabolites using Capillary Electrophoresis Time-of-flight-mass Spectrometry.

Authors:  Masahiro Sugimoto; Sana Ota; Miku Kaneko; Ayame Enomoto; Tomoyoshi Soga
Journal:  Bio Protoc       Date:  2020-10-20

6.  Characteristic proteins in the plasma of postoperative colorectal and liver cancer patients with Yin deficiency of liver-kidney syndrome.

Authors:  Qing Ji; Wenhai Wang; Yunquan Luo; Feifei Cai; Yiyu Lu; Wanli Deng; Qi Li; Shibing Su
Journal:  Oncotarget       Date:  2017-10-11

7.  Metabolic profiling of body fluids and multivariate data analysis.

Authors:  Jean-Pierre Trezzi; Christian Jäger; Sara Galozzi; Katalin Barkovits; Katrin Marcus; Brit Mollenhauer; Karsten Hiller
Journal:  MethodsX       Date:  2017-02-20

8.  Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics.

Authors:  Anna Lindahl; Rainer Heuchel; Jenny Forshed; Janne Lehtiö; Matthias Löhr; Anders Nordström
Journal:  Metabolomics       Date:  2017-04-01       Impact factor: 4.290

9.  Metabolomics identifies metabolite biomarkers associated with acute rejection after heart transplantation in rats.

Authors:  Feng Lin; Yi Ou; Chuan-Zhong Huang; Sheng-Zhe Lin; Yun-Bin Ye
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

Review 10.  Metabolomics in Autoimmune Diseases: Focus on Rheumatoid Arthritis, Systemic Lupus Erythematous, and Multiple Sclerosis.

Authors:  Naeun Yoon; Ah-Kyung Jang; Yerim Seo; Byung Hwa Jung
Journal:  Metabolites       Date:  2021-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.